Stock listing

Lang & Schwarz:A12ETZ Coherus Oncology, Inc. Aktie

German listing (Lang & Schwarz) of Coherus Oncology, Inc. · home listing NASDAQ:CHRS

Follow Coherus Oncology, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CHRS

$0.99 USD -0.08 (-7.5%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CHRS

Since Jul 6, 2026 -36.5% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$0.987 – $1.07 USDOct 16, 2026
Volume
938,496 sharesOct 16, 2026
Market value
$153.0M USDAt the close on Oct 16, 2026 · price × 154.5M shares outstanding
Coherus Oncology, Inc. logo
Ticker
Lang & Schwarz:A12ETZ
Asset type
Stock
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 5:00 PM ET

    Watch Transcript

  • Coherus Oncology (NASDAQ:CHRS) Q1 2026 Earnings Call

    Mon, May 11, 2026 · 5:00 PM ET

    Watch Transcript

  • Coherus Oncology (NASDAQ:CHRS) Q4 2025 Earnings Call

    Mon, Mar 09, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026

Oct 14, 2026

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

Sep 23, 2026

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

Aug 17, 2026

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 5, 2026

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 22, 2026

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)

Jun 23, 2026

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

May 11, 2026

Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026

May 4, 2026

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

Mar 9, 2026

Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026

Mar 2, 2026

All Coherus Oncology, Inc. news

Decks

Coherus Oncology, Inc. on 6ix

News releases
22 in the last 12 months · 156 in all · newest Oct 14, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
Decks
4 decks · latest September 2026

Where Coherus Oncology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CHRS · Home listingNASDAQUnited StatesUSD
Tradegate:8C5TradegateGermanyEUR
gettex:8C5gettexGermanyEUR
Lang & Schwarz:A12ETZ · This pageLang & SchwarzGermanyEUR
LS Exchange:A12ETZLS ExchangeGermanyEUR
BOATS:CHRSBOATSUnited StatesUSD
BX Swiss:8C5BX SwissSwitzerlandCHF
Dusseldorf:8C5DusseldorfGermanyEUR
Frankfurt:8C5FrankfurtGermanyEUR
Munich:8C5MunichGermanyEUR
Stuttgart:8C5StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Coherus Oncology, Inc.